Clinical Trials on CoronaVirus Induced Disease-2019 (COVID-19)

Total 7828 results

AudibleHealth AI, Inc.
Sunrise Research Institute; Analytical Solutions Group, Inc.; Kelley Medical... and other collaborators

Completed

Evaluation of the AudibleHealth Dx AI/ML-Based Dx SaMD Using FCV-SDS in the Diagnosis of COVID-19 Illness: Clinical Validation

Coronavirus Disease 2019 | SARS-CoV-2 Infection | COVID-19 Pandemic | COVID-19 Virus Infection | Coronavirus Disease-19 | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease

United States
Leidos Life Sciences
United States Department of Defense

Active, not recruiting

LEAP-CT for Treatment of COVID-19 Patients (Master Protocol)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
Leidos Life Sciences
United States Department of Defense

Withdrawn

Leidos-Enabled Adaptive Protocol for Clinical Trials (LEAP-CT) in Hospitalized Patients With COVID-19 (Addendum 1)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV-2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection
Leidos Life Sciences
United States Department of Defense

Terminated

Leidos-Enabled Adaptive Protocol (LEAP-CT) for Evaluation of Post-exposure Prophylaxis for Newly-infected COVID-19 Patients (Addendum 2)

COVID-19 | Covid19 | Coronavirus Disease 2019 | SARS-CoV2 Infection | SARS-CoV-2 Acute Respiratory Disease | COVID-19 Pandemic | COVID-19 Virus Infection | COVID-19 Virus Disease | 2019 Novel Coronavirus Disease | 2019 Novel Coronavirus Infection | 2019-nCoV Disease | 2019-nCoV Infection

United States
CSL Behring

Completed

Treatment With CSL312 in Adults With Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

United States
Guangzhou Institute of Respiratory Disease
Tongji Hospital; Guangzhou Eighth People's Hospital; Guangzhou Cellgenes Biotechnology...

Unknown

Bone Marrow-Derived Mesenchymal Stem Cell Treatment for Severe Patients With Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

China
Akesobio Australia Pty Ltd

Completed

A Study of AK119 (Anti-CD73 Antibody), a Treatment for COVID-19, in Healthy Subjects

Coronavirus Disease 2019 (COVID-19)

New Zealand
Materia Medica Holding

Active, not recruiting

Clinical Trial of Efficacy and Safety of Raphamin in the Treatment of Coronavirus Disease 2019 in Outpatients

Coronavirus Disease 2019 (COVID-19)

Russian Federation
AstraZeneca

Completed

A Study to Evaluate the Safety and Tolerability of AZD7442 in Chinese Adults

Coronavirus Disease 2019 (COVID-19)

China
Tychan Pte Ltd.

Completed

Safety of TY027, a Treatment for COVID-19, in Humans

Coronavirus Disease-2019 (COVID-19)

Singapore
AbbVie

Completed

Study to Assess Adverse Events and How Intravenous (IV) ABBV-47D11 and IV ABBV-2B04 Given Alone and in Combination Moves Through the Body of Adult Participants With Coronavirus Disease 2019 (COVID-19)

CoronaVirus Disease-2019 (COVID-19)

United States, Hungary, Israel, Netherlands, Puerto Rico
I-Mab Biopharma Co. Ltd.

Completed

Study of TJ003234 (Anti-GM-CSF Monoclonal Antibody) in Subjects With Severe Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 COVID-19

United States
Prothione, LLC

Completed

A Study to Evaluate the Efficacy and Safety of Prothione™ Capsules for Mild to Moderate Coronavirus Disease 2019 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

Rwanda
CSL Behring

Withdrawn

CSL324 in COVID-19

Coronavirus Disease 2019 (COVID-19)
CSL Behring

Terminated

Pharmacokinetics, Safety, and Tolerability of CSL760, an Intravenous Anti-SARS-CoV-2 Hyperimmune Globulin, in Healthy Adult Subjects

Coronavirus Disease 2019 (COVID-19)

Australia
Janssen Vaccines & Prevention B.V.

Completed

A Study to Evaluate Different Dose Levels of Ad26.COV2.S in Healthy Adolescents From 12 to 17 Years Inclusive (HORIZON 2)

Coronavirus Disease-2019 (COVID-19) Prevention

South Africa, Brazil, Argentina, Mexico, India
AstraZeneca

Terminated

Non-Interventional Enhanced Active Surveillance Study of Adults Vaccinated With AZD1222 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

Germany
Tang-Du Hospital

Completed

Clinical Study of Anti-CD147 Humanized Meplazumab for Injection to Treat With 2019-nCoV Pneumonia

Coronavirus Disease 2019 (COVID-19)

China
Sinocelltech Ltd.

Completed

Safety, Tolerability and Pharmacokinetics of SCTA01, an Anti-SARS-CoV-2 Monoclonal Antibody, in Healthy Chinese Subjects

Coronavirus Disease 2019(COVID-19)

China
Janssen Research & Development, LLC

Terminated

A Study of Rivaroxaban to Reduce the Risk of Major Venous and Arterial Thrombotic Events, Hospitalization and Death in Medically Ill Outpatients With Acute, Symptomatic Coronavirus Disease 2019 (COVID-19) Infection (PREVENT-HD)

Coronavirus Disease 2019 (COVID-19)

United States
National Institute of Allergy and Infectious Diseases...

Completed

Collection of Anti-SARS-CoV-2 Immune Plasma (NIAID)

Coronavirus Disease 2019 (COVID-19)

United States
AstraZeneca

Completed

A Study to Evaluate the Safety and Tolerability of AZD7442 in Healthy Chinese Adults

Healthy Volunteer | Coronavirus Disease 2019 (COVID-19)

China
Fundacion Clinica Valle del Lili
Universidad Autonoma de Occidente

Completed

Convolutional Neural Network Model to Detect Coronavirus Disease 2019 (COVID-19) Pneumonia in Chest Radiographs (RedNeumon)

COVID-19 Pneumonia | COVID-19 (Coronavirus Disease 2019)

Colombia
University Hospital, Basel, Switzerland

Completed

Amotosalen-Ultraviolet A Pathogen-Inactivated Convalescent Plasma in Addition to Best Supportive Care and Antiviral Therapy on Clinical Deterioration in Adults Presenting With Moderate to Severe COVID-19

Coronavirus Disease 2019 Infectious Disease (COVID-19 Infection)

Switzerland
Tychan Pte Ltd.

Terminated

Efficacy and Safety of TY027, a Treatment for COVID-19, in Humans

Coronavirus Disease-2019 (COVID-19)

Singapore
Hospital San Carlos, Madrid

Completed

Increased Risk of Severe Coronavirus Disease 2019 in Patients With Vitamin D Deficiency (COVIT-D)

Coronavirus Disease 2019 (COVID-19)

Spain
Henan Provincial People's Hospital

Unknown

Sequential Oxygen Therapy Strategy for Patients With COVID-19 (SOTSPC)

Coronavirus Disease-2019

China
Hospital Italiano de Buenos Aires
University of Buenos Aires; Ministerio de Salud de Ciudad Autónoma de Buenos...

Completed

Safety and Efficacy of the Coronavirus Disease 2019 Vaccine in Hemodialysis Patients

Renal Dialysis | Coronavirus Disease 2019 Vaccines

Argentina
Volgograd State Medical University

Active, not recruiting

Thrombohemorrhagic Complications of COVID-19

COVID-19 (Coronavirus Disease 2019)

Russian Federation
Lifefactors Zona Franca, SAS

Unknown

Convalescent Plasma (PC) and Human Intravenous Anti-COVID-19 Immunoglobulin (IV Anti COVID-19 IgG) in Patients Hospitalized for COVID-19.

Coronavirus Disease 2019 (COVID-19)

Colombia
Theravance Biopharma

Completed

TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation

Acute Lung Injury (ALI) Due to Coronavirus Disease-2019 (COVID-19)

United States
VA Office of Research and Development
Mayo Clinic

Completed

Observational Study of Convalescent Plasma for Treatment of Veterans With COVID-19

Coronavirus Disease 2019 (COVID-19)

United States
Humanigen, Inc.

Active, not recruiting

Phase 3 Study to Evaluate Efficacy and Safety of Lenzilumab in Patients With COVID-19

Coronavirus Disease 2019 (COVID-19) Pneumonia

United States, Brazil
Dr. Ferrer BioPharma
Hospital CEMESA Cortés, San Pedro Sula, Honduras

Completed

Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-I (ACCROS-I)

Coronavirus Infections | COVID-19 | Coronavirus Disease 2019 | COVID-19 Pandemic | Symptoms and Signs

Honduras
Emmanouil D. Zacharakis

Recruiting

Levels of Physical Activity After SARS-CoV-2 Infection in Pre-illness Vaccinated and Unvaccinated Greek Adults.

COVID-19 (Coronavirus Disease 2019)

Greece
Beijing Ditan Hospital

Completed

A Clinical Study to Assess Preliminary Efficacy, Safety and Tolerability of HH-120 Nasal Spray in COVID-19 Patients

Coronavirus Disease 2019(COVID-19)

China
Guangdong Raynovent Biotech Co., Ltd

Completed

The Safety, Tolerability and Pharmacokinetics Study of RAY1216 in Healthy Adult Participants

COVID-19 (Coronavirus Disease 2019)

China
Yu Qin

Enrolling by invitation

Sequential Enhanced Safety Study of a Novel Coronavirus Messenger RNA (mRNA) Vaccine in Adults Aged 18 Years and Older.

Corona Virus Disease 2019(COVID-19)

China
University of Lahore

Completed

Theranostic Implication of Complementary Medicines Against Interleukin Receptors and Gp-130 Proteins

Corona Virus Disease 2019 (COVID-19)

Pakistan
Stanford University
National Institute of Allergy and Infectious Diseases (NIAID)

Recruiting

Understanding COVID-19 Vaccine Immunity in Tissue and Blood

COVID-19 (Coronavirus Disease 2019)

United States
AstraZeneca

Terminated

A Randomized, Open-label, Dose-ranging Study in Adults and Pediatric Individuals ≥ 12 Years of Age to Assess the Safety, Immunogenicity, Pharmacokinetics, and Pharmacodynamics of AZD7442, for Pre-exposure Prophylaxis of COVID-19 (ENDURE)

Coronavirus Disease 2019 (COVID-19)

United States
Abu Dhabi Stem Cells Center

Completed

Study Evaluating the Safety and Efficacy of Autologous Non-Hematopoietic Peripheral Blood Stem Cells in COVID-19 (SENTAD-COVID)

Coronavirus Disease 2019 (COVID-19)

United Arab Emirates
Fuzhou General Hospital

Unknown

Safety and Effectiveness of Mesenchymal Stem Cells in the Treatment of Pneumonia of Coronavirus Disease 2019

COVID-19 Pneumonia

China
Dr. Ferrer BioPharma
Hospital CEMESA Cortés, San Pedro Sula, Honduras

Completed

Chlorpheniramine Nasal Spray to Accelerate COVID-19 Clinical Recovery in an Outpatient Setting: ACCROS-III (ACCROS-III)

Coronavirus Infections | COVID-19 | Coronavirus Disease 2019 | COVID-19 Pandemic | Symptoms and Signs

Honduras
Bayer
CureVac

Withdrawn

COVID-19: A Trial Studying the SARS-CoV-2 mRNA Vaccine CVnCoV to Learn About the Immune Response, the Safety, and the Degree of Typical Vaccination Reactions When CVnCoV is Given at the Same Time as a Flu Vaccine Compared to When the Vaccines Are Separately Given in Adults 60 Years of Age and Older (CV-NCOV-011)

Coronavirus Disease 2019 (COVID-19) | SARS-CoV-2 Infection
Rambam Health Care Campus

Unknown

Hydroxychloroquine Post-Exposure Prophylaxis for Coronavirus Disease (COVID-19) Among Health-Care Workers

Coronavirus Disease 2019 (COVID-19) | Post-Exposure Prophylaxis

Israel
OncoImmune, Inc.

Completed

Efprezimod Alfa (CD24Fc, MK-7110) as a Non-antiviral Immunomodulator in COVID-19 Treatment (MK-7110-007) (SAC-COVID)

Coronavirus Disease 2019 (COVID-19)

United States
Cluster de Bioeconomia de Baja California, A.C
Bionag SAPI de CV; General Hospital Tijuana

Completed

Evaluation of Silver Nanoparticles for the Prevention of COVID-19 (COVID-19)

Coronavirus Disease 2019 (COVID-19)

Mexico
Kanuni Sultan Suleyman Training and Research Hospital

Completed

Mesenchymal Stem Cells Therapy in Patients With COVID-19 Pneumonia

Coronavirus Disease 2019 (COVID-19) Pneumonia

Turkey
National Institute of Allergy and Infectious Diseases...
Autoimmunity Centers of Excellence; Clinical Trials in Organ Transplantation...

Completed

COVID-19: Pediatric Research Immune Network on SARS-CoV-2 and MIS-C (PRISM)

Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) | Coronavirus Disease 2019 (COVID-19) | Multisystem Inflammatory Syndrome in Children (MIS-C)

United States

Clinical Trials on CoronaVirus Induced Disease-2019 (COVID-19)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations